TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11752122

Group type: EXPERIMENTAL
Intervention: 100 mg of MDMA plus 0.8 g/kg ethanol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 100 mg of MDMA
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.8 g/kg of ethanol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 9615259

Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg om
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: omeprazole 10 mg om
Number of subjects: 704

Group type: COMPARATOR
Intervention: ranitidine 150 mg bd
Number of subjects: 704
Study: 7652070

Group type: EXPERIMENTAL
Intervention: Outpatient wound control after 30 days (group I)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Self-control by questionnaire (group II)
Number of subjects: 315
Study: 2649330

Group type: EXPERIMENTAL
Intervention: Problem solving with self-monitoring of blood glucose (SMBG) integrated into standard outpatient care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 0
Study: 882110

Group type: EXPERIMENTAL
Intervention: Penicillin G administered intravenously every four hours for a total of 50,000 U per kilogram per day
Number of subjects: 0
Study: 31512830

Group type: EXPERIMENTAL
Intervention: Sandblasting with alumina particles at 0.2 MPa pressure (groups A, B, C)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sandblasting with 120 µm particle size at 0.7 MPa pressure (group D)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Acid etching with 98% concentrated sulfuric acid for 60, 120, and 300 s (groups E, F, G)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group H (no surface treatment)
Number of subjects: 48
Study: 28003068

Group type: EXPERIMENTAL
Intervention: Fascia Iliaca Compartment Block (FICB)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Local Anesthetic Infiltration (LAI)
Number of subjects: 46
Study: 26016146

Group type: EXPERIMENTAL
Intervention: Palliative radiotherapy course with a fractional dose of 3 Gy to 42 Gy SOD (SDeq 51 Gy) in group 1 (20 patients)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Radiotherapy using dynamic dose fractionation: fractional doses of 4, 3, and 2 Gy to 51 Gy SDeq in group 2 (20 patients)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined treatment using dynamic dose fractionation: fractional doses of 4, 3, and 2 Gy to 56 Gy SDeq and chemotherapy (Xeloda or ftorafur) in group 3 (20 patients)
Number of subjects: 60
Study: 23167953

Group type: EXPERIMENTAL
Intervention: 50 mg vitamin C
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: 500 mg vitamin C
Number of subjects: 244
Study: 21706269

Group type: EXPERIMENTAL
Intervention: Heparanase-1 (HPA-1) expression in malignant cases
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Vascular endothelial growth factor (VEGF) expression in malignant cases
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Vascular endothelial growth factor receptor-2 (VEGFR-2) expression in malignant cases
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Microvessel density (MVD) in malignant cases
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Correlation of HPA-1 and VEGF with MVD
Number of subjects: 44
Study: 18840118

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided catheter placement with nerve stimulation assistance (US)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Stimulating catheter (ST)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional nerve stimulation (TR)
Number of subjects: 100
Study: 16567439

Group type: EXPERIMENTAL
Intervention: SonoVue contrast agent administration
Number of subjects: 14
Study: 12654143

Group type: EXPERIMENTAL
Intervention: Postural support roll and postural support nappy
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Postural support roll (with or without postural support nappy)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Postural support roll only
Number of subjects: 123

Group type: COMPARATOR
Intervention: Postural support nappy only
Number of subjects: 123
Study: 10781116

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 microg.kg‐1
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Mivacurium 0.04 mg.kg‐1
Number of subjects: 150

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 150
Study: 8640163

Group type: EXPERIMENTAL
Intervention: IL-3 alone (Arm 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sequential IL-3 -> G-CSF (Arm 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sequential IL-3 -> GM-CSF (Arm 3)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined IL-3 + G-CSF (Arm 4)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GM-CSF after PBSC infusion
Number of subjects: 30
Study: 1451712

Group type: EXPERIMENTAL
Intervention: ibuprofen-codeine 200 mg : 30 mg
Number of subjects: 165

Group type: COMPARATOR
Intervention: acetylsalicylic acid-codeine 500 mg : 30 mg
Number of subjects: 165

Group type: COMPARATOR
Intervention: codeine 30 mg
Number of subjects: 165
Study: 6693621

Group type: EXPERIMENTAL
Intervention: Ionescu-Shiley bovine pericardial xenograft in the mitral position
Number of subjects: 70
Study: 31302719

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30297397

Group type: EXPERIMENTAL
Intervention: Atezolizumab (anti-PD-L1)
Number of subjects: 4549
Study: 26358120

Group type: EXPERIMENTAL
Intervention: Preoperative regular diet of 900 kcal/day (group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Preoperative balanced energy high-protein formula (group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Preoperative Immunonutrition (group 3)
Number of subjects: 60
Study: 23884689

Group type: EXPERIMENTAL
Intervention: Items studied aloud
Number of subjects: 0

Group type: COMPARATOR
Intervention: Items studied silently
Number of subjects: 0
Study: 22451451

Group type: EXPERIMENTAL
Intervention: Valsartan (80-160 mg per day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Non-RAS inhibitor treatment
Number of subjects: 150
Study: 19121416

Group type: EXPERIMENTAL
Intervention: Zoledronate 4 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 18214124

Group type: EXPERIMENTAL
Intervention: Cryo group (ice mapping with catheter tip temperature to -40 degrees C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: RF group (radiofrequency ablation using standard techniques)
Number of subjects: 30
Study: 15025891

Group type: EXPERIMENTAL
Intervention: Bioenergy awareness training
Number of subjects: 27
Study: 11830920

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg per day)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Tamoxifen plus CMF (C 500 mg/m2, M 40 mg/m2, F 600 mg/m2 on days 1st and 8th q 28 day for 6 cycles)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 103

Group type: COMPARATOR
Intervention: Tamoxifen plus CMF
Number of subjects: 103
Study: 9552047

Group type: EXPERIMENTAL
Intervention: Adjuvant interferon alfa-2a treatment (3 mIU subcutaneously daily for 3 weeks, then 3 mIU three times per week for 1 year)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 311
Study: 7917369

Group type: EXPERIMENTAL
Intervention: Daily low-dose carboplatin (30 mg/m2 on days 1-5, weeks 1, 3, 5, and 7)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Daily low-dose carboplatin (up to 55 mg/m2)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Daily low-dose carboplatin and radiotherapy (70 Gy)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Daily low-dose carboplatin and radiotherapy (40-45 mg/m2)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Daily low-dose carboplatin and radiotherapy
Number of subjects: 55
Study: 3045901

Group type: EXPERIMENTAL
Intervention: Prilocaine 1% (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mepivacaine 1% (group 2)
Number of subjects: 60
Study: 31977865

Group type: EXPERIMENTAL
Intervention: Afatinib 40 mg/day plus HAD-B1 972 mg
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Afatinib 40 mg/day plus HAD-B1 1944 mg
Number of subjects: 66

Group type: COMPARATOR
Intervention: Afatinib 40 mg/day
Number of subjects: 66
Study: 29457215

Group type: EXPERIMENTAL
Intervention: Propofol-paravertebral anaesthesia
Number of subjects: 397

Group type: COMPARATOR
Intervention: Inhalational agent-opioid anaesthesia
Number of subjects: 397
Study: 26099910

Group type: EXPERIMENTAL
Intervention: Jigsaw method (peer-assisted learning)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Ventilation group (VEN)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (expert instruction)
Number of subjects: 137
Study: 25662002

Group type: EXPERIMENTAL
Intervention: Athletic taping over the thoracic spine
Number of subjects: 10

Group type: COMPARATOR
Intervention: No intervention (pre-intervention state)
Number of subjects: 10
Study: 23921860

Group type: COMPARATOR
Intervention: Lidocaine submucosal injection (1.8 mL of 2% lidocaine with 1:100,000 epinephrine)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Lidocaine spray (four puffs of 10% lidocaine)
Number of subjects: 101
Study: 21751432

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate 50/100 µg bd (SFC)
Number of subjects: 548

Group type: COMPARATOR
Intervention: Montelukast 5 mg od (MON)
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: SFC
Number of subjects: 548

Group type: COMPARATOR
Intervention: MON
Number of subjects: 548
Study: 18154127

Group type: EXPERIMENTAL
Intervention: Dicarbamin 100 mg/day
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Dicarbamin
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: ABVD chemotherapy plus dicarbamin
Number of subjects: 33
Study: 15564817

Group type: EXPERIMENTAL
Intervention: Social cognitive intervention program (n = 42)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Social skills training (n = 40)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Waitlist control group (n = 15)
Number of subjects: 97
Study: 11523070

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9684947

Group type: EXPERIMENTAL
Intervention: 900 mg of hypericum extract with 5.0% hyperforin, once a day for 8 days
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 900 mg of hypericum extract with 0.5% hyperforin, once a day for 8 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 8022682

Group type: EXPERIMENTAL
Intervention: 200 mg caffeine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no caffeine)
Number of subjects: 36
Study: 2736988

Group type: EXPERIMENTAL
Intervention: EACA (5 g prior to skin incision, followed by 1 g/h for 6 to 8 h)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: EACA
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control (saline solution administered in the same fashion)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control
Number of subjects: 350
Study: 1097628

Group type: EXPERIMENTAL
Intervention: Test mouthrinse (Cepacol)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 10
Study: 29281101

Group type: EXPERIMENTAL
Intervention: Sildenafil (40 mg three times daily)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 26252526

Group type: EXPERIMENTAL
Intervention: HIVMAG (x3) prime-Ad35 (x1) boost
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ad35 boost
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: HIVMAG (x3) with or without IL-12
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: HIVMAG (x3) with IL-12
Number of subjects: 75
Study: 24437301

Group type: EXPERIMENTAL
Intervention: Impression technique with a tissue-stop area
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional impression technique
Number of subjects: 20
Study: 21382515

Group type: EXPERIMENTAL
Intervention: Music listening or headphones only for noise cancellation
Number of subjects: 0
Study: 18326282

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg a day for 4 months
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Losartan in combination with non-drug means
Number of subjects: 35
Study: 16585984

Group type: EXPERIMENTAL
Intervention: 308-nm UVB therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: cream PUVA therapy
Number of subjects: 10
Study: 15173792

Group type: EXPERIMENTAL
Intervention: Endoloop ligation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Elastic band ligation
Number of subjects: 50
Study: 11479157

Group type: EXPERIMENTAL
Intervention: Serum cystatin C
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Serum creatinine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Serum beta(2)-microglobulin
Number of subjects: 49
Study: 10186459

Group type: EXPERIMENTAL
Intervention: nabumetone
Number of subjects: 100000

Group type: COMPARATOR
Intervention: ibuprofen
Number of subjects: 100000
Study: 7926499

Group type: EXPERIMENTAL
Intervention: Gastric distention
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Duodenal distention
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Gastric relaxatory responses to duodenal distention
Number of subjects: 10
Study: 2577116

Group type: EXPERIMENTAL
Intervention: 20 mg temazepam
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 234488

Group type: EXPERIMENTAL
Intervention: Diphenhydramine HCl (Benadryl)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cyproheptadine (Periactin)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hydroxyzine HCl (Atarax)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 28
Study: 31257168

Group type: EXPERIMENTAL
Intervention: 5000 JAU of JC pollen (A)
Number of subjects: 1042

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 1042
Study: 27903842

Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle change intervention (diet, exercise, mind-body practice, behavioral counseling) during radiotherapy and for 12 months after
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: In-person lifestyle counseling (42 hours during XRT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Video counseling (up to 30 hours over 12 months)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Qualitative data collection from exit interviews and other sources
Number of subjects: 55
Study: 24867068

Group type: EXPERIMENTAL
Intervention: DHEA 75 mg once a day for 8 weeks before and during IVF treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 23475699

Group type: EXPERIMENTAL
Intervention: Hypertensive pregnant (HTP)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Normotensive pregnant (NTP)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Hypertensive nonpregnant (HTNP)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Normotensive nonpregnant (NTNP)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Hypertensive women during pregnancy
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Nonpregnant women with arterial hypertension (AH)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Pregnancy
Number of subjects: 193
Study: 21585170

Group type: EXPERIMENTAL
Intervention: 2L/d additional water intake
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual fluid consumption (control group)
Number of subjects: 48
Study: 19803239

Group type: EXPERIMENTAL
Intervention: Needle‐sticking method combined with single‐finger meditation pushing therapy at pain points
Number of subjects: 150

Group type: COMPARATOR
Intervention: Local application of Votalin Emulgel combined with Tuina
Number of subjects: 150
Study: 16409461

Group type: EXPERIMENTAL
Intervention: BAY 59-7939 2.5 mg b.i.d.
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: BAY 59-7939 5 mg b.i.d.
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: BAY 59-7939 10 mg b.i.d.
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: BAY 59-7939 20 mg b.i.d.
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: BAY 59-7939 30 mg b.i.d.
Number of subjects: 706

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg once daily (control)
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: BAY 59-7939 (all doses)
Number of subjects: 706
Study: 15156786

Group type: EXPERIMENTAL
Intervention: With visual control
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Without visual control
Number of subjects: 6
Study: 11751721

Group type: EXPERIMENTAL
Intervention: Propranolol (0.21 mg/kg total intravenous dose in 15 minutes)
Number of subjects: 18
Study: 9480620

Group type: EXPERIMENTAL
Intervention: Betadine vaginal suppository (200 mg polyvidonum‐iodine PVP) for 7 days
Number of subjects: 64
Study: 7685895

Group type: EXPERIMENTAL
Intervention: Steroid-eluting lead
Number of subjects: 35

Group type: COMPARATOR
Intervention: Microporous platinum lead
Number of subjects: 35
Study: 3327654

Group type: EXPERIMENTAL
Intervention: diet plus drug (colestipol plus niacin)
Number of subjects: 188

Group type: COMPARATOR
Intervention: diet plus placebo
Number of subjects: 188
Study: 31604475

Group type: EXPERIMENTAL
Intervention: lacosamide (up to 400 mg/day)
Number of subjects: 108

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: lacosamide
Number of subjects: 108
Study: 30165438

Group type: EXPERIMENTAL
Intervention: Microvascular angina (MVA)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Vasospastic angina (VSA)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 81
Study: 27291137

Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention (three sessions over 4 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual counseling from peer educators (control group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Motivational interviewing intervention and Usual counseling (both groups)
Number of subjects: 80
Study: 23996969

Group type: EXPERIMENTAL
Intervention: DCB + BMS
Number of subjects: 77

Group type: COMPARATOR
Intervention: BMS
Number of subjects: 77

Group type: COMPARATOR
Intervention: DES
Number of subjects: 77
Study: 22330261

Group type: EXPERIMENTAL
Intervention: Bilateral TAP block
Number of subjects: 80

Group type: COMPARATOR
Intervention: Local anesthetic infiltration of trocar insertion sites
Number of subjects: 80
Study: 19530009

Group type: EXPERIMENTAL
Intervention: Arabin pessary
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cervical cerclage
Number of subjects: 54
Study: 17688642

Group type: EXPERIMENTAL
Intervention: DTPa‐HBV‐IPV vaccine
Number of subjects: 314
Study: 16380886

Group type: EXPERIMENTAL
Intervention: Glaucoma patients driving with binocular congruent scotomata within the central 30 degrees visual field
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Glaucoma patients fulfilling legal requirements
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Glaucoma patients with visual acuity below mandatory legal requirements
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Glaucoma patients who stopped driving
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Projected number of actively driving glaucoma patients not meeting legal requirements
Number of subjects: 132
Study: 12392812

Group type: COMPARATOR
Intervention: No treatment (untreated participants in wait-list, no-treatment, and placebo conditions)
Number of subjects: 29
Study: 9638984

Group type: EXPERIMENTAL
Intervention: MPO gene expression analysis using Northern blot hybridization and immunohistochemical staining
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MPO gene expression analysis using reverse transcriptase‐polymerase chain reaction assay
Number of subjects: 43
Study: 8184493

Group type: EXPERIMENTAL
Intervention: Intravesical Bacillus Calmette‐Guérin (BCG) treatment for carcinoma in situ (CIS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravesical Bacillus Calmette‐Guérin (BCG) treatment for prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravesical Bacillus Calmette‐Guérin (BCG) treatment for tumor(s)
Number of subjects: 0
Study: 2684039

Group type: EXPERIMENTAL
Intervention: Daily 6-mercaptopurine and weekly methotrexate (neutropenic group)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Daily 6-mercaptopurine and weekly methotrexate (non-neutropenic group)
Number of subjects: 105
Study: 1093670

Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol 5.0 mg/day
Number of subjects: 3774

Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol 1.0 mg/day
Number of subjects: 3774

Group type: COMPARATOR
Intervention: Early endocrine treatment
Number of subjects: 3774

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3774
Study: 30951497

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) quartiles
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Bilirubin levels
Number of subjects: 1096
Study: 27787342

Group type: EXPERIMENTAL
Intervention: Cash incentive intervention
Number of subjects: 0
Study: 26313133

Group type: EXPERIMENTAL
Intervention: Escitalopram (N=127)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo (N=128)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Conventional medical treatment for ACS (N=123)
Number of subjects: 255
Study: 23703228

Group type: EXPERIMENTAL
Intervention: Cartoon and photograph montage storybook
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care (no storybook)
Number of subjects: 100
Study: 22379905

Group type: EXPERIMENTAL
Intervention: Sevoflurane and extended-release epidural anesthesia with Ropivacaine 0.3%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoflurane and epidural anesthesia
Number of subjects: 40
Study: 19407299

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg once daily
Number of subjects: 9581

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg once daily
Number of subjects: 9581
Study: 17539714

Group type: EXPERIMENTAL
Intervention: Coronally positioned flap associated with an acellular dermal matrix graft
Number of subjects: 10

Group type: COMPARATOR
Intervention: Coronally positioned flap associated with a subepithelial connective tissue graft
Number of subjects: 10
Study: 15475417

Group type: EXPERIMENTAL
Intervention: Treatment regimen 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment regimen 2
Number of subjects: 0
Study: 15869585

Group type: EXPERIMENTAL
Intervention: rFXIII (50 U kg(‐1))
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50